J
Juanita Romero-Diaz
Researcher at University Health Network
Publications - 94
Citations - 4861
Juanita Romero-Diaz is an academic researcher from University Health Network. The author has contributed to research in topics: Medicine & Lupus erythematosus. The author has an hindex of 24, co-authored 77 publications receiving 2804 citations. Previous affiliations of Juanita Romero-Diaz include University of Texas Health Science Center at Houston & National Institute of Nutrition, Hyderabad.
Papers
More filters
Journal ArticleDOI
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
Martin Aringer,Karen H. Costenbader,David I. Daikh,Ralph Brinks,Marta Mosca,Rosalind Ramsey-Goldman,Josef S Smolen,David Wofsy,Dimitrios T. Boumpas,Diane L. Kamen,David Jayne,Ricard Cervera,Nathalie Costedoat-Chalumeau,Betty Diamond,Dafna D. Gladman,Bevra H. Hahn,Falk Hiepe,Søren Jacobsen,Dinesh Khanna,Kirsten Lerstrøm,Elena Massarotti,Joseph M. McCune,Guillermo Ruiz-Irastorza,Jorge Sanchez-Guerrero,Matthias Schneider,Murray B. Urowitz,George Bertsias,Bimba F. Hoyer,Nicolai Leuchten,Chiara Tani,Sara K. Tedeschi,Zahi Touma,Gabriela Schmajuk,Branimir Anić,Florence Assan,Tak Mao Chan,Ann E. Clarke,Mary K. Crow,László Czirják,Andrea Doria,Winfried Graninger,Bernadett Halda-Kiss,Sarfaraz Hasni,Peter M. Izmirly,Michelle Jung,Gábor Kumánovics,Xavier Mariette,Ivan Padjen,José M. Pego-Reigosa,Juanita Romero-Diaz,Íñigo Rúa-Figueroa Fernández,Raphaèle Seror,Georg Stummvoll,Yoshiya Tanaka,Maria G Tektonidou,Carlos Vasconcelos,Edward M Vital,Daniel J. Wallace,Sule Yavuz,Pier Luigi Meroni,Marvin J. Fritzler,Ray Naden,Thomas Dörner,Sindhu R. Johnson +63 more
TL;DR: To develop new classification criteria for systemic lupus erythematosus (SLE) jointly supported by the European League Against Rheumatism and the American College of Rheumatology (ACR).
Journal ArticleDOI
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
Martin Aringer,Karen H. Costenbader,David I. Daikh,Ralph Brinks,Marta Mosca,Rosalind Ramsey-Goldman,Josef S Smolen,David Wofsy,Dimitrios T. Boumpas,Dimitrios T. Boumpas,Diane L. Kamen,David Jayne,Ricard Cervera,Nathalie Costedoat-Chalumeau,Betty Diamond,Dafna D. Gladman,Bevra H. Hahn,Falk Hiepe,Søren Jacobsen,Dinesh Khanna,Kirsten Lerstrøm,Elena Massarotti,Joseph M. McCune,Guillermo Ruiz-Irastorza,Jorge Sanchez-Guerrero,Matthias Schneider,Murray B. Urowitz,George Bertsias,Bimba F. Hoyer,Nicolai Leuchten,Chiara Tani,Sara K. Tedeschi,Zahi Touma,Gabriela Schmajuk,Branimir Anić,Florence Assan,Tak Mao Chan,Ann E. Clarke,Mary K. Crow,László Czirják,Andrea Doria,Winfried Graninger,Bernadett Halda-Kiss,Sarfaraz Hasni,Peter M. Izmirly,Michelle Jung,Gábor Kumánovics,Xavier Mariette,Ivan Padjen,José M. Pego-Reigosa,Juanita Romero-Diaz,Íñigo Rúa-Figueroa Fernández,Raphaèle Seror,Georg Stummvoll,Yoshiya Tanaka,Maria G Tektonidou,Carlos Vasconcelos,Edward M Vital,Edward M Vital,Daniel J. Wallace,Sule Yavuz,Pier Luigi Meroni,Marvin J. Fritzler,Ray Naden,Thomas Dörner,Sindhu R. Johnson,Sindhu R. Johnson +66 more
TL;DR: These new classification criteria for systemic lupus erythematosus have excellent sensitivity and specificity, and were developed using rigorous methodology with multidisciplinary and international input.
Journal ArticleDOI
Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
Ian N. Bruce,Aidan G. O'Keeffe,Vernon T. Farewell,John G. Hanly,Susan Manzi,Li Su,Dafna D. Gladman,Sang Cheol Bae,Jorge Sanchez-Guerrero,Juanita Romero-Diaz,Caroline Gordon,Daniel J. Wallace,Ann E. Clarke,Sasha Bernatsky,Ellen M. Ginzler,David A. Isenberg,Anisur Rahman,J. T. Merrill,Graciela S. Alarcón,Barri J. Fessler,Paul R. Fortin,Michelle Petri,Kristjan Steinsson,Mary Anne Dooley,Munther A. Khamashta,Rosalind Ramsey-Goldman,Asad Zoma,Gunnar Sturfelt,Ola Nived,Cynthia Aranow,Meggan Mackay,Manuel Ramos-Casals,Ronald F van Vollenhoven,Kenneth C. Kalunian,Guillermo Ruiz-Irastorza,S. Sam Lim,Diane L. Kamen,Christine A. Peschken,Murat Inanc,Murray B. Urowitz +39 more
TL;DR: It is found that several potentially modifiable risk factors for damage accrual are identified and an integrated strategy to address these may improve long-term outcomes.
Journal ArticleDOI
The frequency and outcome of lupus nephritis: results from an international inception cohort study
John G. Hanly,Aidan G. O'Keeffe,Li Su,Murray B. Urowitz,Juanita Romero-Diaz,Caroline Gordon,Sang Cheol Bae,Sasha Bernatsky,Ann E. Clarke,Daniel J. Wallace,Joan T. Merrill,David A. Isenberg,Anisur Rahman,Ellen M. Ginzler,Paul R. Fortin,Dafna D. Gladman,Jorge Sanchez-Guerrero,Michelle Petri,Ian N. Bruce,Mary Anne Dooley,Rosalind Ramsey-Goldman,Cynthia Aranow,Graciela S. Alarcón,Barri J. Fessler,Kristjan Steinsson,Ola Nived,Gunnar Sturfelt,Susan Manzi,Munther A. Khamashta,Ronald F van Vollenhoven,Asad Zoma,Manuel Ramos-Casals,Guillermo Ruiz-Irastorza,S. Sam Lim,Thomas Stoll,Murat Inanc,Kenneth C. Kalunian,Diane L. Kamen,Peter J. Maddison,Christine A. Peschken,Søren Jacobsen,Anca Askanase,Chris Theriault,Kara Thompson,Vernon T. Farewell +44 more
TL;DR: Despite current standard of care, nephritis was associated with ESRD and death, and renal insufficiency was linked to lower health-related quality of life.
Journal ArticleDOI
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.
Brad H. Rovin,Y K Onno Teng,Ellen M. Ginzler,Cristina Arriens,Dawn J. Caster,Juanita Romero-Diaz,Keisha L. Gibson,Joshua Kaplan,Laura Lisk,Sandra V. Navarra,Samir V. Parikh,Simrat Randhawa,Neil Solomons,Robert B Huizinga +13 more
TL;DR: In this paper, the authors evaluated the efficacy and safety of voclosporin for the treatment of lupus nephritis in a phase 3 trial, where patients were randomly assigned (1:1) to either oral vocosporin (23·7 mg twice daily) or placebo, on a background of mycophenolate mofetil (1 g twice daily), and rapidly tapered low-dose oral steroids, by using an interactive web response system.